Allotera Therapeutics | RoundOS

Weekly digest by email

Loading companies…

Allotera Therapeutics | RoundOS

Weekly digest by email

Funding history

1 round · 1 with disclosed amounts

Announced	Round	Amount	Investors
Jul 8, 2026	Series C	$35M	Banc of California — Role not disclosedBioGenerator — Role not disclosedBlood Cancer United's Therapy Acceleration Program — Role not disclosedFidelity Management & Research Company — Role not disclosedLightchain Capital — Role not disclosed

Investors

Banc of CaliforniaSeries C BioGeneratorSeries C Blood Cancer United's Therapy Acceleration ProgramSeries C Fidelity Management & Research CompanySeries C Lightchain CapitalSeries C

Coverage

Jul 8, 2026Allotera Therapeutics · Series C

Similar companies

AusperBioDevelops oligonucleotide therapeutics targeting chronic hepatitis B$120M · Series C

ProFound TherapeuticsUses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia$35M · Strategic

TransfyrPhysical AI platform capturing real-world lab science into machine-readable data$25M · Seed

Sources

alloteratx.com ↗